Retour
63
39
59
Également cotée sous
WUXAY
OTC
Fourchette du Jour
13,88 €
15,00 €
Fourchette 52 Semaines
7,34 €
16,80 €
Volume
600
Moyenne 50J / 200J
14,12 €
/
12,83 €
Clôture Précédente
13,88 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (626 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 4,4 | 0,4 |
| P/B | 0,7 | 2,9 |
| ROE % | 16,6 | 3,7 |
| Net Margin % | 24,1 | 3,9 |
| Rev Growth 5Y % | 24,1 | 10,0 |
| D/E | 0,1 | 0,2 |
Objectif de Cours des Analystes
Aucune couverture d'analyste disponible
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2028 |
7,38 €
6,90 € – 8,04 €
|
68 B | 1 |
| FY2027 |
6,43 €
6,01 € – 7,01 €
|
59 B | 1 |
| FY2026 |
5,60 €
5,24 € – 6,10 €
|
52 B | 1 |
Points Clés
Revenue grew 24,12% annually over 5 years — strong growth
ROE of 16,62% — decent returns on equity
Net margin of 24,08% shows strong profitability
Debt/Equity of 0,08 — conservative balance sheet
Generating 8,40B in free cash flow
P/E of 4,38 — trading at a low valuation
Croissance
Revenue Growth (5Y)
24,12%
Revenue (1Y)-2,73%
Earnings (1Y)-1,63%
FCF Growth (3Y)259,46%
Qualité
Return on Equity
16,62%
ROIC13,70%
Net Margin24,08%
Op. Margin29,51%
Sécurité
Debt / Equity
0,08
Current Ratio2,38
Interest Coverage53,60
Valorisation
P/E Ratio
4,38
P/B Ratio0,71
EV/EBITDA2,40
Dividend Yield0,02%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -2,73% | Revenue Growth (3Y) | -0,14% |
| Earnings Growth (1Y) | -1,63% | Earnings Growth (3Y) | 3,55% |
| Revenue Growth (5Y) | 24,12% | Earnings Growth (5Y) | 33,67% |
| Profitability | |||
| Revenue (TTM) | 39,24B | Net Income (TTM) | 9,45B |
| ROE | 16,62% | ROA | 11,76% |
| Gross Margin | 41,48% | Operating Margin | 29,51% |
| Net Margin | 24,08% | Free Cash Flow (TTM) | 8,40B |
| ROIC | 13,70% | FCF Growth (3Y) | 259,46% |
| Safety | |||
| Debt / Equity | 0,08 | Current Ratio | 2,38 |
| Interest Coverage | 53,60 | Dividend Yield | 0,02% |
| Valuation | |||
| P/E Ratio | 4,38 | P/B Ratio | 0,71 |
| P/S Ratio | 1,06 | PEG Ratio | 12,27 |
| EV/EBITDA | 2,40 | Dividend Yield | 0,02% |
| Market Cap | 41,41B | Enterprise Value | 27,84B |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 39,24B | 40,34B | 39,35B | 22,90B | 16,54B |
| Net Income | 9,45B | 9,61B | 8,81B | 5,10B | 2,96B |
| EPS (Diluted) | 3,26 | 3,24 | 2,82 | 1,73 | 1,05 |
| Gross Profit | 16,28B | 16,57B | 14,68B | 8,31B | 6,28B |
| Operating Income | 11,58B | 11,87B | 10,65B | 6,04B | 3,39B |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 80,33B | 73,67B | 64,69B | 55,13B | 46,29B |
| Total Liabilities | 21,24B | 18,15B | 17,76B | 16,37B | 13,57B |
| Shareholders' Equity | 58,63B | 55,12B | 46,59B | 38,49B | 32,49B |
| Total Debt | 4,75B | 5,45B | 5,87B | 4,28B | 4,29B |
| Cash & Equivalents | 18,32B | 13,76B | 7,99B | 8,24B | 10,24B |
| Current Assets | 38,69B | 30,42B | 24,00B | 21,99B | 23,06B |
| Current Liabilities | 16,23B | 14,76B | 14,50B | 12,98B | 7,92B |
Scores de Stratégies
This stock passed the criteria for 3 strategies
Score = fit strength (0–100)
Rank = position among all matches
#104 of 820
#239 of 658
#75 of 708
Activité Récente
Entré
Deep Value Investing (Seth Klarman)
Mar 24, 2026
Entré
Contrarian Investing (David Dreman)
Mar 24, 2026
Entré
Defensive Investing (Benjamin Graham)
Mar 24, 2026